Nuclear imaging of neuroinflammation: A comprehensive review of [ 11C]PK11195 challengers

Fabien Chauveau, Hervé Boutin, Nadja Van Camp, Frédéric Dollé, Bertrand Tavitian

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Neurodegenerative, inflammatory and neoplastic brain disorders involve neuroinflammatory reactions, and a biomarker of neuroinflammation would be useful for diagnostic, drug development and therapy control of these frequent diseases. In vivo imaging can document the expression of the peripheral benzodiazepine receptor (PBR)/translocator protein 18 kDa (TSPO) that is linked to microglial activation and considered a hallmark of neuroinflammation. The prototype positron emission tomography tracer for PBR, [11C]PK11195, has shown limitations that until now have slowed the clinical applications of PBR imaging. In recent years, dozens of new PET and SPECT radioligands for the PBR have been radiolabelled, and several have been evaluated in imaging protocols. Here we review the new PBR ligands proposed as challengers of [ 11C]PK11195, critically analyze preclinical imaging studies and discuss their potential as neuroinflammation imaging agents. © 2008 Springer-Verlag.
    Original languageEnglish
    Pages (from-to)2304-2319
    Number of pages15
    JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
    Volume35
    Issue number12
    DOIs
    Publication statusPublished - Dec 2008

    Keywords

    • [11C]PK11195
    • Neuroinflammation
    • Peripheral benzodiazepine receptor (PBR)
    • PET
    • Translocator protein 18kDa (TSPO)

    Fingerprint

    Dive into the research topics of 'Nuclear imaging of neuroinflammation: A comprehensive review of [ 11C]PK11195 challengers'. Together they form a unique fingerprint.

    Cite this